Clinical Trial Update: White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating white fish for cardiovascular risk factors in patients with metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Metabolic Syndrome

Snippet

Sponsor: Hospital Universitario Ramon y Cajal | Conditions: Cardiovascular Risk Factors, Metabolic Syndrome | Phase 3 | Status: COMPLETED